An innovative approach helped researchers analyze the role of protein-protein interactions (PPIs) in cases of hypertrophic cardiomyopathy (HCM), a discovery that could advance precision medicine...
In a collaborative study among life sciences companies, oncology providers, and patient advocacy groups, researchers will evaluate up to 12,000 community-based, metastatic non-small cell lung cancer...
Genetic data can help improve prostate cancer risk prediction in diverse racial and ethnic groups, leading to more targeted, personalized screenings, according to a study published in Nature...
To increase precision medicine adoption, healthcare leaders must build education among patients and providers, implement advanced infrastructure, and boost patient engagement, according to a report...
As disease treatments continue to advance and become more personalized, researchers are increasingly relying on genomic data to accelerate the development of precision medicine for a range of...
UCLA has received a $29 million gift to establish a precision medicine center where scientists can leverage big data and genomic technologies to improve genetic disease treatment and diagnosis.
The...
Researchers from the University of Maryland School of Medicine (UMSOM) have analyzed diverse genetic datasets in an effort to advance precision medicine for minority populations.
The early analysis is...
Intermountain Primary Children’s Hospital has launched the HerediGene: Children’s Study, an effort to speed the development of precision medicine therapies for children with genetic...
Using predictive analytics algorithms, a universal screening tool can accurately determine an adolescent’s suicide risk and alert providers of which patients are in need of follow-up...
Researchers from the University of Alabama at Birmingham have created a genetic database designed to help advance precision medicine treatments for COVID-19.
The database, called PAGER-CoV-2, includes...
The Henry Ford Cancer Institute at Henry Ford Health System has launched the Brigitte Harris Cancer Pavilion, a facility that will include specialty clinics for 14 different types of cancer, precision...
To improve breast cancer risk assessment, providers should perform genetic testing in women who aren’t at high risk of developing the disease, according to a study published in The New England...
A team from UT Southwestern (UTSW) has found that a significant number of breast cancer patients have higher levels of the ZMYND8 gene, making it a potential target for immunotherapies and precision...
Potential jurors may not be strongly opposed to providers’ acceptance of artificial intelligence medical recommendations, indicating that clinicians may be less liable for medical malpractice...
Researchers from the Johns Hopkins departments of oncology and pathology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University (JHU) School of Medicine, and 18 other organizations...
Genetic markers related to mineral bone accrual could help providers identify younger patients at risk of fractures in later life, according to a study published in Genome Biology.
Osteoporosis is a...
A new tool that focuses on RNA could accelerate the development of precision medicine treatments for incurable diseases, including a type of metastatic breast cancer, according to a study published in...
Researchers at the Perelman School of Medicine at the University of Pennsylvania have received a $4.8 million grant from the National Institute on Aging (NIA) to study the genetics of Alzheimer’s...
NIH’s All of Us precision medicine research program is beginning to return genetic results to participants, with individuals now able to receive information about their genetic ancestry and...
Researchers from Penn Medicine have discovered a new biomarker that identifies which patients with aggressive lymphoma won’t respond to a precision medicine treatment called ibrutinib.
The...
